Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -8.40% is 149% below its 5-year average of 17.06%, near the low end of its 5-year range (-8.40%–65.02%).
112.39% below its 12-month average of -3.96%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
-8.40%
RETURN ON ASSETS (ROA) AVG TTM
-3.96%
RETURN ON ASSETS (ROA) AVG 3Y
9.16%
RETURN ON ASSETS (ROA) AVG 5Y
17.06%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-112.39%
CURRENT VS 3Y AVG
-191.65%
CURRENT VS 5Y AVG
-149.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-263.42%
vs the sector median at left
BioNTech SE
Market Cap
$24.78B
Return on Assets (ROA)
-8.40%
TTM Avg
-3.96%
3Y Avg
9.16%
5Y Avg
17.06%
Market Cap
$25.22B
Return on Assets (ROA)
20.48%
TTM Avg
9.54%
3Y Avg
8.43%
5Y Avg
7.44%
Market Cap
$23.79B
Return on Assets (ROA)
13.86%
TTM Avg
12.54%
3Y Avg
14.20%
5Y Avg
14.86%
Market Cap
$25.99B
Return on Assets (ROA)
6.27%
TTM Avg
5.75%
3Y Avg
6.24%
5Y Avg
8.30%
Market Cap
$26.64B
Return on Assets (ROA)
5.41%
TTM Avg
4.41%
3Y Avg
4.42%
5Y Avg
6.18%
Market Cap
$26.79B
Return on Assets (ROA)
24.67%
TTM Avg
25.02%
3Y Avg
24.63%
5Y Avg
23.85%
Market Cap
$21.14B
Return on Assets (ROA)
18.16%
TTM Avg
16.59%
3Y Avg
14.73%
5Y Avg
13.22%
Market Cap
$29.33B
Return on Assets (ROA)
1.76%
TTM Avg
3.17%
3Y Avg
1.75%
5Y Avg
1.75%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNTech SE (BNTX) | $24.78B | -8.40% | -3.96% | 9.16% | 17.06% |
| Incyte Corporation (INCY)vs › | $25.22B | 20.48% | 9.54% | 8.43% | 7.44% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.79B | 13.86% | 12.54% | 14.20% | 14.86% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.99B | 6.27% | 5.75% | 6.24% | 8.30% |
| Labcorp Holdings Inc. (LH)vs › | $26.64B | 5.41% | 4.41% | 4.42% | 6.18% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.79B | 24.67% | 25.02% | 24.63% | 23.85% |
| STERIS plc (STE)vs › | $21.29B | 7.50% | 6.68% | 4.44% | 4.33% |
| United Therapeutics Corporation (UTHR)vs › | $21.14B | 18.16% | 16.59% | 14.73% | 13.22% |
| Medline Inc. (MDLN)vs › | $29.33B | 1.76% | 3.17% | 1.75% | 1.75% |
| Waters Corporation (WAT)vs › | $30.13B | 0.67% | 13.34% | 15.53% | 17.15% |
ROA
-8.4%
ROE
-9.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -4.96% |
| 2024-12-31 | -2.95% |
| 2023-12-31 | 4.04% |
| 2022-12-31 | 40.53% |
| 2021-12-31 | 65.02% |
| 2020-12-31 | 0.66% |
| 2019-12-31 | -22.45% |
| 2018-12-31 | -7.35% |
| 2017-12-31 | -22.86% |
| 2016-12-31 | 0.00% |
